New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful ...
Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...
Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...
Pharmacy Times Continuing Education™ (PTCE) presented new research at the American Diabetes Association (ADA) 2026 Scientific Sessions, held June 5–8 in New Orleans, Louisiana. The ADA Scientific ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results